14
Oct 2026
Common asthma drug improves strength in children with muscle disease
A common asthma medication improves motor skills and muscle strength in children with congenital myopathies, a group of incurable muscle diseases.
Stay Informed!
14
Oct 2026
Chronic inflammation spikes during the earliest phase of cardiovascular-kidney-metabolic syndrome
In a nationally representative sample of more than 4,000 American adults, a common marker of inflammation was nearly doubled in people in the first stage of the syndrome, defined by excess or unhealthy body fat, compared with those with no metabolic risk factors.
14
Oct 2026
Finnish study finds poor oral health increases jawbone necrosis risks in breast cancer patients
Antiresorptive drugs, which reduce bone breakdown, are an important part of treatment for breast cancer that has spread to the bones. However, their use can be associated with osteonecrosis of the jaw (MRONJ), a condition in which bone tissue in the jaw dies.
14
Oct 2026
Mosquito saliva study opens new doors for blocking Zika, Dengue, and West Nile infections
Mosquitoes do more than simply transmit the viruses they carry: their saliva may actively help these viruses establish infection in the body from the very moment of the bite.
14
Oct 2026
Improving healthcare sustainability through carbon data
Healthcare sustainability data can identify emissions hotspots and improve operational decision-making across healthcare and life sciences.
14
Oct 2026
Seragy launches with €12 million financing to advance quantitative biomarkers for neurodegenerative diseases
seragy holding GmbH (formerly Prosperodes GmbH), a biomarker strategy company focused on neurodegenerative diseases and other proteopathies, has secured €12 million in funding to accelerate the development of its SeRAS® platform (Seed Replication, Analysis and Subtyping) and expand its laboratory and analytical capabilities. The financing is backed by Commerzbank, the Mittelständische Beteiligungsgesellschaft (MBG), and the State of Lower Saxony.
14
Oct 2026
Chemists develop blueprint for designing powerful fluorescent materials for better disease detection
Chemists at the University of Bath have discovered how tiny molecular changes can transform the color and brightness of fluorescent probes based on the blue molecule azulene, paving the way for more powerful imaging tools for detecting diseases such as Alzheimer's, Parkinson’s and cancer.
14
Oct 2026
Scientists identify novel autoimmune driver behind DNA repair breakdown in childhood cancer
A team of scientists in Norway has found evidence for a new, previously unknown mechanism for the development of cancer in children: they seem to produce an unusual amount of aberrant antibodies against the building blocks that make up the DNA repair machinery, a diverse set of hundreds of proteins which identify and correct damage or errors in the genome.
14
Oct 2026
New research links postmenopausal ovarian tissue remodeling to elevated cancer vulnerability
In a new, paradigm-shifting study in ovaries from 28 women, scientists at Northwestern University and the Buck Institute for Research on Aging found in the decades well past menopause, the ovary remains biologically active and continues to remodel with age, showing increased inflammation and changes in tissue structure. The study also found a molecular link between ovarian aging and cancer.
14
Oct 2026
People who walk more each day tend to score better on several brain tests
Researchers analyzed 14 years of physical activity and blood pressure records from 3,093 US adults and found that higher daily step counts were associated with better performance on tests of attention, cognitive control, and reward-related decision-making. Higher systolic blood pressure was associated with poorer delay-discounting performance, but accounted for only 4.8% of its association with physical activity, while the single cognitive assessment prevented conclusions about causation or cognitive decline.
